---
title: "Ironwood names Jeffrey Silber chief medical officer, succeeding Michael Shetzline"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292616752.md"
description: "Ironwood Pharmaceuticals has appointed Jeffrey Silber as its new Chief Medical Officer and Head of Research and Drug Development, succeeding the retiring Michael Shetzline. Silber, previously CMO at Vedanta Biosciences, will report to CEO Tom McCourt and oversee regulatory, medical, and development affairs. He starts July 20, 2026, while Shetzline remains an advisor during the transition."
datetime: "2026-07-14T11:30:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292616752.md)
  - [en](https://longbridge.com/en/news/292616752.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292616752.md)
---

# Ironwood names Jeffrey Silber chief medical officer, succeeding Michael Shetzline

-   Ironwood named Jeffrey Silber chief medical officer, head of research and drug development, succeeding retiring CMO Michael Shetzline. \* Silber starts July 20, 2026; Shetzline will stay on as an advisor during the transition. \* Silber will oversee research and drug development, regulatory affairs, medical affairs, reporting to CEO Tom McCourt. \* He joins from Vedanta Biosciences, where he served as chief medical officer since 2020, leading microbiome-based GI therapy development. \* Earlier roles included senior vice president in clinical development at EMD Serono/Merck KGaA, vice president at AbbVie, leadership posts at Merck. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ironwood Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260714515996) on July 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [IRWD.US](https://longbridge.com/en/quote/IRWD.US.md)
- [MRK.DE](https://longbridge.com/en/quote/MRK.DE.md)
- [MKKGY.US](https://longbridge.com/en/quote/MKKGY.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Ironwood Pharmaceuticals’ Jeffrey Silber, SVP and CMO, files initial beneficial ownership statement](https://longbridge.com/en/news/293514414.md)
- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)
- [James Michael Morrissey Expands Holdings With $54K Incyte Stock Options Acquisition](https://longbridge.com/en/news/294085325.md)
- [Sofwave Medical executives join Needham Virtual MedTech & Diagnostics 1x1 Conference](https://longbridge.com/en/news/293929475.md)
- [Compounded GLP-1 drugs creating concern among doctors and FDA](https://longbridge.com/en/news/293924807.md)